TipRanks
BioMark Diagnostics (DE:20B)
FRANKFURT:20B
Germany Market
20B
BioMark Diagnostics
RESEARCH TOOLSreports

BioMark Diagnostics (20B) Income Statement

5 Followers

BioMark Diagnostics Income Statement

Last quarter (Q4 2026), BioMark Diagnostics's total revenue was C$7.01K, a decrease of -82.03% from the same quarter last year. In Q4, BioMark Diagnostics's net income was C$-199.47K. See BioMark Diagnostics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 26Jun 25Jun 24Jun 22Jun 21
Total Revenue
C$ 59.79KC$ 154.22KC$ 163.22KC$ 153.49KC$ 0.00
Gross Profit
C$ -322.49KC$ 154.22KC$ 163.22KC$ -232.70KC$ -13.69K
Operating Expenses
C$ 1.55MC$ 2.06MC$ 1.48MC$ 1.89MC$ 1.08M
Depreciation and Amortization
C$ 382.28KC$ 401.27KC$ 393.17KC$ 386.20KC$ 13.69K
EBITDA
C$ -1.49MC$ -1.46MC$ -919.05KC$ -1.35MC$ -1.08M
Operating Income
C$ -1.87MC$ -1.91MC$ -1.32MC$ -1.84MC$ -1.09M
Other Income/Expenses
C$ 268.36KC$ -19.14KC$ -110.67KC$ -110.15KC$ -596.00
Pretax Income
C$ -1.60MC$ -1.93MC$ -1.43MC$ -1.84MC$ -1.09M
Net Income
C$ -1.48MC$ -1.93MC$ -1.43MC$ -1.84MC$ -1.09M
Per Share Metrics
Basic EPS
C$ -0.01C$ -0.02C$ -0.02C$ -0.02C$ -0.01
Diluted EPS
C$ -0.01C$ -0.02C$ -0.02C$ -0.02C$ -0.01
Weighted Average Shares Outstanding
 105.09M 85.24M 85.24M 82.78M 73.30M
Weighted Average Shares Outstanding (Diluted)
 105.09M 85.24M 85.24M 82.78M 73.30M
Currency in CAD

BioMark Diagnostics Earnings and Revenue History